H.C. Wainwright raised the firm’s price target on Balchem (BCPC) to $190 from $185 and keeps a Buy rating on the shares post the Q3 report. The firm continues to consider Balchem a bright spot within the human and animal nutrition and health arena.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter